Franklin, MA – Prestige Scientific is excited to announce the successfully completed search for a Vice President of Clinical Development with our partner, a biopharmaceutical company focused on developing innovative therapies for some of the most aggressive and treatment-resistant forms of cancer.
The individual hired for this role is an accomplished Clinical Development executive with extensive experience steering oncology drug development across both solid and hematologic cancers, from pre IND to regulatory approval. They have led the advancement of diverse modalities including antibody drug conjugates, cytotoxics, kinase inhibitors, immunotherapies, and hormonal treatments, managing global Phase I–III programs, registration strategies, and regulatory engagements with FDA, EMA, and PMDA. With expertise spanning trial design, companion diagnostic development, pharmacovigilance, CRO oversight, and NDA/BLA submissions, they’ve built and led cross functional teams, partnerships, and global collaborations to deliver therapies that improve patient outcomes.
As a key member of the Clinical Development team, this critical hire will have a direct impact on advancing novel treatments, will work closely with top-tier investigators and collaborators, and will help shape programs from early development through pivotal trials for our partner.
Prestige presented 12 individuals for this role, the hired candidate was presented 12 days from the start of the search and the project was completed in 44 days. Congratulations to our Clinical search team for this successful project!
About Prestige Scientific:
Prestige Scientific is an executive search firm that advises our clients on recruiting impactful leaders. We provide our clients with a performance-based hiring system that identifies leaders with past success meeting similar corporate objectives as their own, while overcoming challenges and adhering to critical timelines. We have dedicated experts in eleven practice areas that mirror a typical biopharma company, allowing us to support our client's growth from Discovery through Commercial.
